216 related articles for article (PubMed ID: 10235608)
1. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis.
Ware JH; Wan XS; Newberne P; Kennedy AR
Dig Dis Sci; 1999 May; 44(5):986-90. PubMed ID: 10235608
[TBL] [Abstract][Full Text] [Related]
2. Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis.
Lichtenstein GR; Deren JJ; Katz S; Lewis JD; Kennedy AR; Ware JH
Dig Dis Sci; 2008 Jan; 53(1):175-80. PubMed ID: 17551835
[TBL] [Abstract][Full Text] [Related]
3. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice.
Arbogast S; Smith J; Matuszczak Y; Hardin BJ; Moylan JS; Smith JD; Ware J; Kennedy AR; Reid MB
J Appl Physiol (1985); 2007 Mar; 102(3):956-64. PubMed ID: 17110517
[TBL] [Abstract][Full Text] [Related]
4. The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.
Gran B; Tabibzadeh N; Martin A; Ventura ES; Ware JH; Zhang GX; Parr JL; Kennedy AR; Rostami AM
Mult Scler; 2006 Dec; 12(6):688-97. PubMed ID: 17262995
[TBL] [Abstract][Full Text] [Related]
5. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
Kennedy AR
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
[TBL] [Abstract][Full Text] [Related]
6. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
[TBL] [Abstract][Full Text] [Related]
7. Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC).
Witschi H; Espiritu I
Cancer Lett; 2002 Sep; 183(2):141-6. PubMed ID: 12065088
[TBL] [Abstract][Full Text] [Related]
8. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.
Yavelow J; Collins M; Birk Y; Troll W; Kennedy AR
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5395-9. PubMed ID: 3860869
[TBL] [Abstract][Full Text] [Related]
9. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
[TBL] [Abstract][Full Text] [Related]
10. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans.
Evans SM; Van Winkle T; Szuhaj B; Michel KE; Kennedy AR
Radiat Res; 1992 Nov; 132(2):259-62. PubMed ID: 1438709
[TBL] [Abstract][Full Text] [Related]
11. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
[TBL] [Abstract][Full Text] [Related]
12. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.
Kennedy AR; Szuhaj BF; Newberne PM; Billings PC
Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077
[TBL] [Abstract][Full Text] [Related]
13. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
Kennedy AR; Beazer-Barclay Y; Kinzler KW; Newberne PM
Cancer Res; 1996 Feb; 56(4):679-82. PubMed ID: 8630994
[TBL] [Abstract][Full Text] [Related]
14. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
Touil T; Ciric B; Ventura E; Shindler KS; Gran B; Rostami A
J Neurol Sci; 2008 Aug; 271(1-2):191-202. PubMed ID: 18544456
[TBL] [Abstract][Full Text] [Related]
15. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
Ware JH; Wan XS; Kennedy AR
Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813
[TBL] [Abstract][Full Text] [Related]
16. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
[TBL] [Abstract][Full Text] [Related]
17. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor.
Witschi H; Kennedy AR
Carcinogenesis; 1989 Dec; 10(12):2275-7. PubMed ID: 2591017
[TBL] [Abstract][Full Text] [Related]
18. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia.
Malkowicz SB; McKenna WG; Vaughn DJ; Wan XS; Propert KJ; Rockwell K; Marks SH; Wein AJ; Kennedy AR
Prostate; 2001 Jun; 48(1):16-28. PubMed ID: 11391683
[TBL] [Abstract][Full Text] [Related]
19. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
[TBL] [Abstract][Full Text] [Related]
20. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.
Fereidunian A; Sadeghalvad M; Oscoie MO; Mostafaie A
Arch Med Res; 2014 Aug; 45(6):455-61. PubMed ID: 25014623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
